Stocks
Axsome Therapeutics (AXSM) P/E US GAAP (year values) |
|||||||||
| 2022 | 2022 | 2023 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| P/E | ? | -16.8 | -16.8 | -15.1 | -14.1 | -49.6 | -46.0 | ||
| Changes by years, y/y, % | +54% | 0% | -10% | -7% | +251% | +11.5% | |||
Axsome Therapeutics. P/E
Axsome Therapeutics. P/E, changes, %
Axsome Therapeutics (AXSM) P/E US GAAP (quarter values) |
||||||||
| 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | LTM ? | |||
| P/E | ? | -20.5 | -20.9 | -26.5 | -50.5 | -46.0 | -46.0 | |
| Changes by years, y/y, % | +61% | +68% | +90% | +253% | +124% | |||
| Changes by quarters, q/q, % | +43% | +2% | +27% | +91% | -9% | |||
